Compounds > ibogaine
Page last updated: 2024-09-05

ibogaine and s,n,n'-tripropylthiocarbamate

ibogaine has been researched along with s,n,n'-tripropylthiocarbamate in 6 studies

Compound Research Comparison

Studies
(ibogaine)		Trials
(ibogaine)		Recent Studies (post-2010)
(ibogaine)		Studies
(s,n,n'-tripropylthiocarbamate)		Trials
(s,n,n'-tripropylthiocarbamate)		Recent Studies (post-2010) (s,n,n'-tripropylthiocarbamate)
445813625,9821,22616,193

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blackburn, JR; Szumlinski, KK1
Glick, SD; Maisonneuve, IM; Szumlinski, KK1
Parker, LA; Siegel, S1
Fleck, MW; Glick, SD; He, LW; Jokiel, PA; Kuehne, ME; Maisonneuve, IM; Pace, CJ1
Ross, S1
Willyard, C1

Reviews

1 review(s) available for ibogaine and s,n,n'-tripropylthiocarbamate

ArticleYear
Modulation of the effects of rewarding drugs by ibogaine.
    The Alkaloids. Chemistry and biology, 2001, Volume: 56

    Topics: Animals; Drug Synergism; Humans; Ibogaine; Learning; Morphine; Reward; Substance Withdrawal Syndrome; Substance-Related Disorders

2001

Other Studies

5 other study(ies) available for ibogaine and s,n,n'-tripropylthiocarbamate

ArticleYear
Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction.
    Behavioural brain research, 1997, Volume: 89, Issue:1-2

    Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cues; Dopamine; Dopamine Antagonists; Drug Interactions; Food Preferences; Ibogaine; Male; Motor Activity; Psychotropic Drugs; Rats; Reward; Substance-Related Disorders; Synaptic Transmission; Taste

1997
The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.
    Brain research, 2000, May-02, Volume: 864, Issue:1

    Topics: Animals; Dopamine; Drug Administration Schedule; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Ibogaine; Microdialysis; Morphine; Morphine Dependence; Motor Activity; Narcotics; Neurons; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reward; Synaptic Transmission; Time Factors

2000
Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration.
    European journal of pharmacology, 2004, May-25, Volume: 492, Issue:2-3

    Topics: Amphetamine-Related Disorders; Animals; Cell Line; Dose-Response Relationship, Drug; Female; Humans; Ibogaine; Morphine Dependence; Nicotinic Antagonists; Patch-Clamp Techniques; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Reward; Self Administration; Tabernaemontana

2004
Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies.
    The Psychiatric clinics of North America, 2012, Volume: 35, Issue:2

    Topics: Adult; Animals; Behavior, Addictive; Clinical Trials as Topic; Cognition; Dopamine; Dopamine Agonists; Glutamates; Hallucinogens; Humans; Ibogaine; Lysergic Acid; Neuronal Plasticity; Nucleus Accumbens; Phytotherapy; Prefrontal Cortex; Psilocybin; Religion; Reward; Serotonin 5-HT2 Receptor Agonists; Substance Withdrawal Syndrome; Substance-Related Disorders

2012
Pharmacotherapy: Quest for the quitting pill.
    Nature, 2015, Jun-25, Volume: 522, Issue:7557

    Topics: Animals; Behavior, Addictive; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clinical Trials as Topic; Cocaine-Related Disorders; Counseling; Dopamine; Drug Discovery; Drug Industry; Humans; Ibogaine; Lobeline; Molecular Targeted Therapy; Naloxone; Naltrexone; Oligopeptides; Opioid-Related Disorders; Pleasure; Rats; Receptors, Nicotinic; Reward; Substance-Related Disorders; Tobacco Use Disorder; Vaccines; Vesicular Monoamine Transport Proteins

2015